SCHEMBL9909807

SCHEMBL9909807

CCCCCCCCCCCC(=O)Nc1ccc(-c2c3nc(c(-c4ccc(C)cc4)c4ccc([nH]4)c(-c4ccc(C)cc4)c4nc(c(-c5ccc(C)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ RAB9A P51151 3/20 0.50
▸ LMNA P02545 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HDAC3 O15379 3/20 0.49
▸ HDAC1 Q13547 3/20 0.49
▸ HDAC2 Q92769 3/20 0.49
▸ HDAC10 Q969S8 3/20 0.49
▸ HDAC11 Q96DB2 2/20 0.49
▸ HDAC8 Q9BY41 2/20 0.49
▸ HDAC6 Q9UBN7 2/20 0.49
▸ NCOR2 Q9Y618 1/20 0.49
▸ GAA P10253 3/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ HDAC4 P56524 1/20 0.47
▸ HDAC7 Q8WUI4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9909802 0.91 HDAC1 (0.51) ALDH1A1LMNAHDAC3HDAC1HDAC2
SCHEMBL9910535 0.81 ABCG2 (0.55) ALDH1A1RAB9ALMNAHPGDSMN1; SMN2
SCHEMBL5968936 0.79 HDAC3 (0.76) ALDH1A1RAB9ALMNAHPGDSMN1; SMN2
SCHEMBL13254437 0.79 HDAC3 (0.76) ALDH1A1RAB9ALMNAHPGDSMN1; SMN2
SCHEMBL9320350 0.79 HDAC3 (0.76) ALDH1A1RAB9ALMNAHPGDSMN1; SMN2
SCHEMBL2531377 0.79 HDAC3 (0.76) ALDH1A1RAB9ALMNAHPGDSMN1; SMN2
SCHEMBL17252159 0.79 HDAC3 (0.76) ALDH1A1RAB9ALMNAHPGDSMN1; SMN2
SCHEMBL16923748 0.78 ALDH1A1 (0.55) ALDH1A1RAB9AHPGDGAAMEN1
SCHEMBL9287004 0.77 TOP1 (0.53) HPGDHDAC3HDAC1HDAC2HDAC10
SCHEMBL26420478 0.77 HDAC3 (0.75) ALDH1A1RAB9ALMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8192917-B2 Material for multiphoton fluorescence microscope and multiphoton fluorescence microscope RICOH COMPANY, LTD. (JP) 2012-06-05 — — US disclosed
US-20090323508-A1 PHOTOSENSITIZED COMPOSITE MATERIAL, THREE-DIMENSIONAL MEMORY MATERIAL AND RECORDING MEDIUM, OPTICAL POWER LIMITING MATERIAL AND ELEMENT, AND PHOTOCURING MATERIAL AND STEREOLITHOGRAPHY SYSTEM, AND FLUORESCENT MATERIAL FOR MULTIPHOTON FLUORESCENCE MICROSCOPE AND MULTIPHOTON FLUORESCENCE MICROSCOPE RICOH COMPANY, LTD. (JP) 2009-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090323508-A1 PHOTOSENSITIZED COMPOSITE MATERIAL, THREE-DIMENSIONAL MEMORY MATERIAL AND RECORDING MEDIUM, OPTICAL POWER LIMITING MATERIAL AND ELEMENT, AND PHOTOCURING MATERIAL AND STEREOLITHOGRAPHY SYSTEM, AND FLUORESCENT MATERIAL FOR MULTIPHOTON FLUORESCENCE MICROSCOPE AND MULTIPHOTON FLUORESCENCE MICROSCOPE HTR3D, ORAI3, GRIN3A ALDH1A1 1777/4885RAB9A 1305/4885LMNA 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback